Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion [Seeking Alpha]
Outset Medical, Inc. (OM)
Company Research
Source: Seeking Alpha
Leslie Trigg, President, CEO & Chairman, reported that 2025 was "a year of progress and transformation at Outset Medical," highlighting substantial cost reductions and significant investments in technology and service leadership. She emphasized the FDA clearance of the Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights Management cited that FDA clearance and enhanced cybersecurity will generate incremental customer interest, potentially providing a revenue tailwind for 2026 and beyond. Market reach is expected to expand as Tablo is used at over 1,000 acute care sites with new large customer agreements signed. 2026 revenue guidance is $125–$130 million (5–9% growth over 2025); gross margin is expected in the low to mid-40% range; management expects improved cash discipline with less cash usage than in 2025 ($46 million). Key risks cited in
Show less
Read more
Impact Snapshot
Event Time:
OM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OM alerts
High impacting Outset Medical, Inc. news events
Weekly update
A roundup of the hottest topics
OM
News
- Outset Medical (NASDAQ:OM) had its price target lowered by analysts at BTIG Research from $17.00 to $15.00. They now have a "buy" rating on the stock.MarketBeat
- Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Outset Medical Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Outset Medical Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating [Yahoo! Finance]Yahoo! Finance
OM
Earnings
- 2/11/26 - Miss
OM
Sec Filings
- 2/11/26 - Form 8-K
- 2/11/26 - Form SCHEDULE
- 1/27/26 - Form 8-K
- OM's page on the SEC website